Clinical Trial

Study on Violence Against Vulnerable Women and Optimizing Support Services

Study acronym: ENVVOL
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Sexual and gender-based violence in France primarily affects women, who make up 88% of victims, with 670,000 affected annually. Many suffer abuse from partners, including 94,000 rape cases, and minors are heavily impacted. Despite frequent emergency visits, medical follow-up is inconsistent, and these violences significantly reduce women's healthy life expectancy. The study aims to assess quality of life improvements six months after multidisciplinary care in specialized centers like "La Maison des Femmes" (The Women's House).
Protocol Amendment History 1 change
critical Primary endpoint(s) modified 2026-07-19
Trial Details
NCT Number NCT07701629
Lead Sponsor Centre Hospitalier Universitaire de Nīmes
Conditions Female Genital Mutilation, Woman Abuse, Abuse, Sexual, Spouse Abuse
Enrollment 70 participants
Start Date 2026-09-15
Primary Completion 2026-11-15 (estimated)
Study Completion 2027-05-15 (estimated)
Updated on ClinicalTrials.gov 2026-07-17